Table 3.
Post-Hoc GEE model including vascular risk factors significantly associated with cognition in individual models
Beta (95% CI) | p-value | |
---|---|---|
intercept | −1.251 (−3.05, 0.55) | 0.17 |
time (diagnosis on) | 0.302 (−0.031, 0.640) | 0.08 |
Female | 0.073 (−0.168, 0.313) | 0.55 |
African-American | −0.219 (−0.665, 0.226) | 0.34 |
Hispanic | −0.292 (−0.733, 0.150) | 0.20 |
Education (per additional year) | 0.038 (0.019, 0.057) | <0.001 |
Age at diagnosis (per additional year) | −0.010 (−0.023, 0.002) | 0.11 |
cohort (1999 vs 1992) | 0.008 (−0.099, 0.114) | 0.89 |
Time between lipid draw and AD incidence | 0.003 (−0.050, 0.057) | 0.90 |
diabetes history | −0.082 (−0.296, 0.133) | 0.45 |
time * diabetes history | −0.046 (−0.106, 0.014) | 0.14 |
LDL-C | 0.000 (−0.003, 0.002) | 0.67 |
time * LDL-C | −0.001 (−0.002, 0.000) | 0.001 |
HDL-C (log-transformed) | 0.252 (−0.059, 0.562) | 0.11 |
time * Log HDL-C | −0.060 (−0.144, 0.023) | 0.16 |
Significant factors associated with differential change in cognition over time are bolded. Time was expressed in years.